Sign up here to become a Direct Purchase Customer.
Alternatively, please call 1-888-495-6078 or email Alexso, Inc. at orders@alexso.com.
For existing customers, click here to place your order: orders@alexso.com
Over 15 million Americans use a statin to help lower cholesterol
69% of older patients report difficulty swallowing pills
FloLipid is available in 20mg/5mL & 40mg/5mL formulations
NO REFRIGERATION REQUIRED
Smooth liquid/syrup consistency and texture with a pleasant strawberry flavor
THE FIRST AND ONLY FDA APPROVED
LIQUID STATIN THAT HELPS LOWER CHOLESTEROL
15 million
Americans use a statin drug for thier cholesterol
69%
Of older patients reported difficulty swallowing pills
Only
Statin medication available in liquid form
Or send us an email at orders@alexso.com
FloLipid Oral Suspension
20mg/ 5mL
Strength: 20mg per 5mL
Quantity: 1 bottle (150mL)
Concentration 4mg per mL
Prescription Only
Or send us an email at orders@alexso.com
FloLipid Oral Suspension
40mg/ 5mL
Strength: 40mg per 5mL
Quantity: 1 bottle (150mL)
Concentration 8mg per mL
Prescription Only
Or send us an email at orders@alexso.com
INDICATIONS
FloLipid™ Oral Suspension (simvastatin) is an HMG-CoA reductase inhibitor indicated as an adjunct to diet to:
- Reduce the risk of total mortality by reducing coronary heart disease (CHD) deaths and to reduce the risk of non-fatal myocardial infarction,
stroke, and the need for coronary and non-coronary revascularization procedures in patients at high risk of coronary events
- Reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), and triglycerides (TG) and
increase high-density lipoprotein cholesterol (HDL-C) in patients with primary hyperlipidemia (heterozygous familial and nonfamilial) and mixed dyslipidemia
- Reduce elevated TG in patients with hypertriglyceridemia and reduce TG and very-low-density lipoprotein cholesterol (VLDL-C) in patients with primary dysbetalipoproteinemia
- Reduce total-C and LDL-C in adult patients with homozygous familial hypercholesterolemia
- Reduce elevated total-C, LDL-C, and Apo B in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
- Limitations of Use: FloLipid Oral Suspension has not been studied in Fredrickson types I and V hyperlipidemia
IMPORTANT SAFETY INFORMATION
FloLipid Oral Suspension is contraindicated:
- With concomitant administration of strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, or danazol
- In patients with a known hypersensitivity to any component of the medication
- In patients with active liver disease or unexplained persistent elevations in hepatic transaminase levels
- In women who are or may become pregnant or who are nursing
Increased risk of myopathy, including rhabdomyolysis, has been associated with the 80-mg dose of FloLipid Oral Suspension
- Risk increases with concomitant use of certain medicines
- Predisposing factors include advanced age (≥65), female gender, uncontrolled hypothyroidism, and renal impairment
- Patients should be advised to report promptly any unexplained and/or persistent muscle pain, tenderness, or weakness
- FloLipid Oral Suspension therapy should be discontinued immediately if myopathy is diagnosed or suspected
- Monitoring of creatine phosphokinase levels is merited in patients with a history of renal insufficiency
For more information, please see the full Prescribing Information and Patient Information for FloLipid Oral Suspension
Click above for product information